Delivery Order SPE2DB22D2005-SPE2DB25FJJB9

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,030.03 and is a firm fixed-price contract running through July 2024. The contract provides for the delivery of Fentanyl 100 mcg/2 mL vials to support U.S. government medical requirements. No set-aside designation was used. AmerisourceBergen holds a larger Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,168.51, is for the supply of 4563927584 Fentanyl 100 MCG/2 ML vials. The contract is a Firm Fixed Price arrangement and has a completion date of March 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $2,673.80 and has a period of performance through February 7, 2025. The contract is for the procurement of 4,567,197,246 units of FENTANYL 100 MCG/2 ML VIAL 2ML, a critical pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,258.56, is for the supply of Fentanyl 100 mcg/2 mL vials. The order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562300693 Fentanyl 100 MCG/2 ML Vial 2ML, a critical pharmaceutical product. The contract has a ceiling value of $1,387.87 and is a Firm Fixed Price Delivery Order with a completion date of September 22, 2023. This award is not associated with a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,778,745 units of 100 mcg/2 ml fentanyl vials, at a ceiling value of $2,277.66. It is a firm fixed-price contract with an ultimate completion date of December 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Fentanyl 100 mcg/2 ml vials. The $1,041.78 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense that manages medical supply chains. The contract has an ultimate completion date of November 29, 2024 and was awarded on November 27, 2024. This award is a delivery order under a larger...
This federal contract award, valued at $1,367.70, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with DLA, valued at $999,999,999 and running through November 2026. This IDC enables the government to procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $1,226.92 and is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major component of the U.S. Department of Defense (DoD), to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company. The $1,216.32 firm-fixed-price delivery order is for the supply of 4,565,087,824 units of Fentanyl 100 mcg/2 ml vials, a critical pain medication used in military healthcare settings. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJJB9
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of Fentanyl 100 MCG/2 ML Vial 2 ML, a critical medication for medical treatment. The contract has a ceiling value of $1,074.98 and runs through March 3, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/30/25, 9:56 AM